The Food and Drug Administration (FDA) has given us approval to proceed with our Investigational New Drug (IND) application allowing for the initiation of a clinical study of an FDA-approved cell therapy (HCP, cord blood) for treatment of acute ischemic stroke.
Our results show our cellular products are safe and effective in the improvement of symptoms related to chronic inflammation, spinal cord injury, stroke, musculoskeletal disorders and other medical conditions.The studies have been conducted following approval by an Investigational Research Board and in accordance with Good Clinical Practice. Blue Horizon Advisors comprises of leading investment professionals in London and the UAE and is part of the wider Blue Horizon group that undertakes global. Our stem cell products evaluated in clinical studies are collected in accordance with Good Tissue Practice to ensure safety.Our recent research has been published in “Experimental and therapeutic medicine” cited at PubMed Central, US National Library of Medicine, National Institutes of Health “CellR4”, the official journal of The Cure Alliance and presented at the American Academy of Orthopedic Surgeons Annual Meeting (New Orleans, LA, 2018), Adult Stem Cells and Regenerative Medicine Conference, The New York Academy of Sciences (NY, 2019), 7th Annual German Stem Cell Network Conference (Germany, Berlin, 2019).We are fully licensed by the Ministry of Health of the Slovak Republic to offer cord blood, bone marrow and adipose stem cell derived treatments at Malacky Hospital near Bratislava, Slovakia. We are the only treatment provider approved and associated with The Wuhan University Department of Medicine, The Biochemistry Institute of Wuhan University. We have safely and efficiently performed more than 4,000 stem cell therapies to date. The Blue Horizon Stem Cell Therapy Program ONLY utilizes stem cells from either your own body or umbilical cord donors whom have proceeded through a. Blue Horizon International is the world’s leading provider of adult and children’s stem cell therapies.
0 kommentar(er)
